Skip to main content
. 2018 Mar 19;15(5):4229–4242. doi: 10.3892/etm.2018.5966

Figure 3.

Figure 3.

Kaplan-Meier survival curves of patients with stage III colorectal carcinoma. (A) OS and (B) DFS in all wild-type vs. RAS/BRAF mutations. (C) OS and (D) DFS in low C-MET expression vs. C-MET overexpression of entire study population. OS, overall survival; DFS, disease-free survival; C-MET, c-mesenchymal epithelial transition factor; CI, confidence interval.